<DOC>
	<DOC>NCT00700947</DOC>
	<brief_summary>The purpose of this study tests whether a beta-blocker drug will benefit patients with chronic mitral regurgitation.</brief_summary>
	<brief_title>Using Beta Blockers to Treat Mitral Regurgitation</brief_title>
	<detailed_description>The purpose of this study tests whether Toprol xl, a beta-blocker drug, will benefit patients with chronic mitral regurgitation after mitral valve surgery and to investigation effects of chronic mitral regurgitation on heart size, heart function, exercise capacity and clinical symptoms.</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Mitral Valve Insufficiency</mesh_term>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Adrenergic beta-Antagonists</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>diagnosis of Mitral Regurgitation Left ventricle ejection fraction of &lt;55% pre and post operation Pregnancy or Lactation Secondary mitral regurgitation due to coronary artery disease, cardiomyopathy, uncontrolled hypertension, or severe aortic stenosis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Heart Disease</keyword>
	<keyword>Mitral Regurgitation</keyword>
	<keyword>Heart Valve Disease</keyword>
	<keyword>Mitral Valve Insufficiency</keyword>
	<keyword>Heart Surgery</keyword>
	<keyword>Heart Valve Surgery</keyword>
</DOC>